We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 1000kg
Contract Manufacturing: CRO,CMO
Packaging Information: 10kg/barrel
Delivery Lead Time: 7-50days
Sample Provided: yes
Payment Terms: T/T
Product Details
Product name
Telmisartan
Purity
99%
Appearance
White Crystalline powder
CAS NO
144701-48-4
Molecular Formula
C33H30N4O2
Shelf life
2 years
Telmisartan tablets, hypertension for the treatment of essential hypertension in adults. Reduce cardiovascular risk. This product is suitable for age 55 and above. To reduce the incidence of myocardial infarction in patients who are at high risk for serious cardiovascular events and cannot be treated with ACE inhibitors. Risk of death from stroke or cardiovascular disease. The high risk of cardiovascular events includes coronary artery disease. History of high-risk type 2 diabetes (insulin-dependent or non-insulin-dependent) with peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage. Telmisartan can also be used in conjunction with other necessary treatments (such as blood pressure medications). Antiplatelet agents or lipid-lowering agents).
Application&Function
Telmisartan tablets, hypertension for the treatment of essential hypertension in adults. Reduce cardiovascular risk. This product is suitable for age 55 and above. To reduce the incidence of myocardial infarction in patients who are at high risk for serious cardiovascular events and cannot be treated with ACE inhibitors. Risk of death from stroke or cardiovascular disease. The high risk of cardiovascular events includes coronary artery disease. History of high-risk type 2 diabetes (insulin-dependent or non-insulin-dependent) with peripheral artery disease, stroke, transient ischemic attack, or evidence of end-organ damage. Telmisartan can also be used in conjunction with other necessary treatments (such as blood pressure medications). Antiplatelet agents or lipid-lowering agents).